News

Published on 12 Nov 2024 on Benzinga

AstraZeneca Q3 Earnings Preview: Will Cancer, Heart Drugs Fuel Continued Growth?...

Article preview image

AstraZeneca plc AZN is set to report its third-quarter 2024 earnings Tuesday morning, and the company's second-quarter performance hints at robust growth fueled by its oncology and cardiovascular portfolios.

What To Know: In the second quarter, AstraZeneca reported $12.94 billion in revenue, marking a 13% year-over-year increase (17% at constant currency), surpassing analysts' expectations of $12.75 billion.

Read the rest of the article
NASDAQ.AZN price evolution
LSE.AZN price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
George Soros Makes a Strategic Move with a 6.25% Stake in Smurfit WestRock PLC

The stock traded at an average price of $31.58 during the quarter. Portfolio Overview As of...

GuruFocus.com · via Yahoo Finance 15 Nov 2024
Is AstraZeneca a Buy as It Eyes the Weight Loss Market?

Down” alerts for three incredible companies, and there may not be another chance like this anytim...

The Motley Fool · via AOL 14 Nov 2024
Vanguard Health Care Fund's Strategic Moves in Q3 2024: A Focus on Zoetis Inc

The stock's average trading price was $1,112.86 during the quarter, with a -30.47% return over th...

GuruFocus.com · via Yahoo Finance 14 Nov 2024
AstraZeneca talks up US growth as China problems fester - The Boston Globe

AstraZeneca Plc is increasingly looking to the United States for growth as its once fast-expandin...

The Boston Globe 13 Nov 2024
AstraZeneca Plc (AZN) Q3 2024 Earnings Call Transcript

Firstly, all of the materials presented today are available on our AstraZeneca Investor Relations...

The Motley Fool · via AOL 13 Nov 2024
AstraZeneca Lifts 2024 Forecast On Better Than Expected Q3 Performance, Says It...

AstraZeneca Plc (NASDAQ:AZN) reported third-quarter sales of $13.57 billion, up 18% year over yea...

Benzinga · via AOL 13 Nov 2024
AstraZeneca Lifts 2024 Forecast On Better Than Expected Q3 Performance, Says It...

AstraZeneca Plc (NASDAQ:AZN) reported third-quarter sales of $13.57 billion, up 18% year over yea...

Benzinga · via Yahoo Finance 12 Nov 2024
AstraZeneca Q3 Earnings Preview: Will Cancer, Heart Drugs Fuel Continued Growth?...

AstraZeneca plc AZN is set to report its third-quarter 2024 earnings Tuesday morning, and the com...

Benzinga 12 Nov 2024
Earnings To Watch: AstraZeneca PLC (OSTO:AZN) Reports Q3 2024 Result

Based on the consensus recommendation from 7 brokerage firms, AstraZeneca PLC's (OSTO:AZN) averag...

GuruFocus.com · via Yahoo Finance 11 Nov 2024
Is AstraZeneca PLC (AZN) The Best UK Stock to Invest in Now?

We recently compiled a list of the 10 Best UK Stocks to Invest in Now. In this article, we are go...

Insider Monkey · via Yahoo Finance 10 Nov 2024

Copyright Statfolio @ 2024

Social Accounts